AKT1 and breast carcinoma: Specifically, it is involved in cell growth and carcinogenesis [14], breast cancer reoccurrence after chemotherapy resistance [15], luteal sensitivity to PGF [16] and, finally, it is part of antiapoptotic (P13K/AKT) and cell proliferation (ERK/MAPK) pathways [17].